Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications.
Nagel K, Ramachandran R, Lipska K. Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications. Diabetes Care 2024, 47: 1246-1256. PMID: 38536964, PMCID: PMC11272967, DOI: 10.2337/dci23-0042.Peer-Reviewed Original ResearchOut-of-pocket paymentsInflation ratePrice hikesPolicy prescriptionsPriceReduced priceHealth insuranceMarket entryPolicy evaluationDrug pricesGovernment negotiatorsBiosimilar competitionPharmacy benefit managersAnticompetitive practicesInflationFederal interventionIncreased enforcementPolicyInsulin pricesPublication productivityReduction ActFederal levelDrug manufacturersBenefit managersCompetitionMedicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data
Qureshi O, Ramachandran R, Ross J. Medicare Part B and Part D drug eligibility for center for Medicare and Medicaid Services price negotiation under the Inflation Reduction Act: estimates using 2016–2019 data. Journal Of Pharmaceutical Policy And Practice 2024, 17: 2312374. PMID: 38434725, PMCID: PMC10906125, DOI: 10.1080/20523211.2024.2312374.Peer-Reviewed Original ResearchDrug spendingPrice negotiationsPrescription drug expendituresAnnual drug spendingInflation Reduction ActMedicare pricesSpending dataReduction ActMedicare spendingDrug expendituresSpendingDrug pricesCenters for Medicare & Medicaid ServicesMedicare Part BInflationPriceAnnual Medicare spendingEligibility requirementsMedicareNegotiationExpenditure